Terms: = Thyroid cancer AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2
34113 results:
1. Deciphering the progression of fine-needle aspiration: A bibliometric analysis of thyroid nodule research.
Liu T; Yang F; Qiao J; Mao M
Medicine (Baltimore); 2024 May; 103(20):e38059. PubMed ID: 38758913
[TBL] [Abstract] [Full Text] [Related]
2. Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review.
Zhao H; Kang W; Guan J; Wang Y
Medicine (Baltimore); 2024 May; 103(20):e38237. PubMed ID: 38758843
[TBL] [Abstract] [Full Text] [Related]
3. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of thyroid cancer.
Fu G; Chazen RS; MacMillan C; Witterick IJ
JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
[TBL] [Abstract] [Full Text] [Related]
4. Rare Columnar Cell Variant of Papillary thyroid Carcinoma with Cervical Spine Metastasis: A Case Report.
Yu J; Yang G; Oh HY; Ryu YJ
Curr Med Imaging; 2024; 20(1):e15734056300884. PubMed ID: 38752631
[TBL] [Abstract] [Full Text] [Related]
5. Trends and projections of the global burden of thyroid cancer from 1990 to 2030.
Hu S; Wu X; Jiang H
J Glob Health; 2024 May; 14():04084. PubMed ID: 38751316
[TBL] [Abstract] [Full Text] [Related]
6. A CT based radiomics analysis to predict the CN0 status of thyroid papillary carcinoma: a two- center study.
Li Z; Zhong Y; Lv Y; Zheng J; Hu Y; Yang Y; Li Y; Sun M; Liu S; Guo Y; Zhang M; Zhou L
Cancer Imaging; 2024 May; 24(1):62. PubMed ID: 38750551
[TBL] [Abstract] [Full Text] [Related]
7. Feasibility and complications after transoral endoscopic thyroidectomy via vestibular approach (TOETVA) - a single-center first experience case series.
Kinet S; van Weezelenburg MAS; Pijnenburg A; Stoot JHMB; van Bastelaar J
Langenbecks Arch Surg; 2024 May; 409(1):158. PubMed ID: 38748236
[TBL] [Abstract] [Full Text] [Related]
8. RPGRIP1L as a new biomarker for prognosis and tumor immune of breast cancer.
Yi J; Liu L; Chen Y; Ding T; Fan P; Yu J; Zeng J
FASEB J; 2024 May; 38(9):e23624. PubMed ID: 38747001
[TBL] [Abstract] [Full Text] [Related]
9. [Imaging characteristics and diagnosis of primary middle mediastinal tumors].
Chen JQ; Wang JW
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):449-456. PubMed ID: 38742358
[No Abstract] [Full Text] [Related]
10. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
[TBL] [Abstract] [Full Text] [Related]
11. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
[TBL] [Abstract] [Full Text] [Related]
12. Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity.
Ballico M; Alessi D; Aneggi E; Busato M; Zuccaccia D; Allegri L; Damante G; Jandl C; Baratta W
Molecules; 2024 May; 29(9):. PubMed ID: 38731639
[TBL] [Abstract] [Full Text] [Related]
13. In situ ascending aortic thrombus in a patient with metastatic lung adenocarcinoma and no aortic atherosclerosis or cisplatin exposure: a case report.
Mehta C; Raza F
J Med Case Rep; 2024 May; 18(1):243. PubMed ID: 38730499
[TBL] [Abstract] [Full Text] [Related]
14. Columnar Cell thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary thyroid Carcinoma and Follicular Neoplasms.
Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
[TBL] [Abstract] [Full Text] [Related]
15. Low TSH and low T3 hormone levels as a prognostic for mortality in COVID-19 intensive care patients.
Sror-Turkel O; El-Khatib N; Sharabi-Nov A; Avraham Y; Merchavy S
Front Endocrinol (Lausanne); 2024; 15():1322487. PubMed ID: 38726342
[TBL] [Abstract] [Full Text] [Related]
16. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell thyroid Carcinoma.
Tian Y; He L; Zhang B; Deng L; Wang J
Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
[No Abstract] [Full Text] [Related]
17. Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance.
Zheng W; Tang X; Dong J; Feng J; Chen M; Zhu X
Sci Rep; 2024 May; 14(1):10546. PubMed ID: 38719979
[TBL] [Abstract] [Full Text] [Related]
18. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract] [Full Text] [Related]
19. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
Park J; An S; Bae JS; Kim JS; Kim K
Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
[TBL] [Abstract] [Full Text] [Related]
20. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
[Next]
